|
1
|
Smith S, Harmanci H, Hutin Y, Hess S,
Bulterys M, Peck R, Rewari B, Mozalevskis A, Shibeshi M, Mumba M,
et al: Global progress on the elimination of viral hepatitis as a
major public health threat: An analysis of WHO member state
responses 2017. JHEP Rep. 1:81–89. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen S, Hu Q, Chen H, Zhang FF, Duan L,
Wang B, Li DD, Zhang J and Chen WX: Identification of serum CMTM2
as a potential biomarker for HBV-related disorders. Dis Markers.
2020(2032056)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Boni C, Fisicaro P, Valdatta C, Amadei B,
Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A,
Missale G, et al: Characterization of hepatitis B virus
(HBV)-specific T-cell dysfunction in chronic HBV infection. J
Virol. 81:4215–4225. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Maini MK, Boni C, Lee CK, Larrubia JR,
Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, et al:
The role of virus-specific CD8(+) cells in liver damage and viral
control during persistent hepatitis B virus infection. J Exp Med.
191:1269–1280. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chyuan IT, Tsai HF, Tzeng HT, Sung CC, Wu
CS, Chen PJ and Hsu PN: Tumor necrosis factor-alpha blockage
therapy impairs hepatitis B viral clearance and enhances T-cell
exhaustion in a mouse model. Cell Mol Immunol. 12:317–325.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen W, Shi M, Shi F, Mao Y, Tang Z, Zhang
B, Zhang H, Chen L, Chen L, Xin S and Wang FS: HBcAg-pulsed
dendritic cell vaccine induces Th1 polarization and production of
hepatitis B virus-specific cytotoxic T lymphocytes. Hepatol Res.
39:355–365. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tang TJ, de Man RA, Kusters JG, Kwekkeboom
J, Hop WCJ, van der Molen RG, Schalm SW and Janssen HLA:
Intrahepatic CD8 T-lymphocytes and HBV core expression in relation
to response to antiviral therapy for chronic hepatitis B patients.
J Med Virol. 72:215–222. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gao G and Luo H: The ubiquitin-proteasome
pathway in viral infections. Can J Physiol Pharmacol. 84:5–14.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Dai S, Chen X, Yu Y, Zang G and Tang Z:
Immunization with lentiviral vector-modified dendritic cells
encoding ubiquitinated hepatitis B core antigen promotes Th1
differentiation and antiviral immunity by enhancing p38 MAPK and
JNK activation in HBV transgenic mice. Mol Med Rep. 18:4691–4699.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dai S, Zhuo M, Song L, Chen X, Yu Y, Tang
Z and Zang G: Dendritic cell-based vaccination with lentiviral
vectors encoding ubiquitinated hepatitis B core antigen enhances
hepatitis B virus-specific immune responses in vivo. Acta Biochim
Biophys Sin (Shanghai). 47:870–879. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dai S, Zhuo M, Song L, Chen X, Yu Y, Zang
G and Tang Z: Lentiviral vector encoding ubiquitinated hepatitis B
core antigen induces potent cellular immune responses and
therapeutic immunity in HBV transgenic mice. Immunobiology.
221:813–821. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chuma M, Terashita K and Sakamoto N: New
molecularly targeted therapies against advanced hepatocellular
carcinoma: From molecular pathogenesis to clinical trials and
future directions. Hepatol Res. 45:E1–E11. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, Du
Z and Yin H: Tumor-derived exosomes elicit tumor suppression in
murine hepatocellular carcinoma models and humans in vitro.
Hepatology. 64:456–472. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Taïeb J, Chaput N and Zitvogel L:
Dendritic cell-derived exosomes as cell-free peptide-based
vaccines. Crit Rev Immunol. 25:215–223. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Besse B, Charrier M, Lapierre V, Dansin E,
Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F,
Laplanche A, et al: Dendritic cell-derived exosomes as maintenance
immunotherapy after first line chemotherapy in NSCLC.
Oncoimmunology. 5(e1071008)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Escudier B, Dorval T, Chaput N, André F,
Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S,
et al: Vaccination of metastatic melanoma patients with autologous
dendritic cell (DC) derived-exosomes: results of thefirst phase I
clinical trial. J Transl Med. 3(10)2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Morse MA, Garst J, Osada T, Khan S,
Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A,
et al: A phase I study of dexosome immunotherapy in patients with
advanced non-small cell lung cancer. J Transl Med.
3(9)2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen JH, Yu YS, Chen XH, Liu HH, Zang GQ
and Tang ZH: Enhancement of CTLs induced by DCs loaded with
ubiquitinated hepatitis B virus core antigen. World J
Gastroenterol. 18:1319–1327. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gardner A and Ruffell B: Dendritic cells
and cancer immunity. Trends Immunol. 37:855–865. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li J, Huang S, Zhou Z, Lin W, Chen S, Chen
M and Ye Y: Exosomes derived from rAAV/AFP-transfected dendritic
cells elicit specific T cell-mediated immune responses against
hepatocellular carcinoma. Cancer Manag Res. 10:4945–4957.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nigro A, Finardi A, Ferraro MM, Manno DE,
Quattrini A, Furlan R and Romano A: Selective loss of microvesicles
is a major issue of the differential centrifugation isolation
protocols. Sci Rep. 11(3589)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li H, Yang C, Shi Y and Zhao L: Exosomes
derived from siRNA against GRP78 modified bone-marrow-derived
mesenchymal stem cells suppress Sorafenib resistance in
hepatocellular carcinoma. J Nanobiotechnology.
16(103)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gao X, Wan Z, Wei M, Dong Y, Zhao Y, Chen
X, Li Z, Qin W, Yang G and Liu L: Chronic myelogenous leukemia
cells remodel the bone marrow niche via exosome-mediated transfer
of miR-320. Theranostics. 9:5642–5656. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tatu RF, Anuşca DN, Groza SŞ, Marusciac L,
Bojin FM, Tatu C, Hurmuz M and Păunescu V: Morphological and
functional characterization of femoral head drilling-derived
mesenchymal stem cells. Rom J Morphol Embryol. 55:1415–1422.
2014.PubMed/NCBI
|
|
25
|
Chen X, Liu H, Tang Z, Yu Y and Zang G:
The modification of Tapasin enhances cytotoxic T lymphocyte
activity of intracellularly delivered CTL epitopes via cytoplasmic
transduction peptide. Acta Biochim Biophys Sin (Shanghai).
45:203–212. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ganem D and Prince AM: Hepatitis B virus
infection-natural history and clinical consequences. N Engl J Med.
350:1118–1129. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tsai SL, Sheen IS, Chien RN, Chu CM, Huang
HC, Chuang YL, Lee TH, Liao SK, Lin CL, Kuo GC, et al: Activation
of Th1 immunity is a common immune mechanism for the successful
treatment of hepatitis B and C: Tetramer assay and therapeutic
implications. J Biomed Sci. 10:120–135. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Phillips S, Chokshi S, Riva A, Evans A,
Williams R and Naoumov NV: CD8(+) T cell control of hepatitis B
virus replication: direct comparison between cytolytic and
noncytolytic functions. J Immunol. 184:287–295. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cargill T and Barnes E: Therapeutic
vaccination for treatment of chronic hepatitis B. Clin Exp Immunol.
205:106–118. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pitt JM, Charrier M, Viaud S, André F,
Besse B, Chaput N and Zitvogel L: Dendritic cell-derived exosomes
as immunotherapies in the fight against cancer. J Immunol.
193:1006–1011. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Andre F, Escudier B, Angevin E, Tursz T
and Zitvogel L: Exosomes for cancer immunotherapy. Ann Oncol. 15
(Suppl 4):iv141–iv144. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
EL Andaloussi S, Mäger I, Breakefield XO
and Wood MJ: Extracellular vesicles: Biology and emerging
therapeutic opportunities. Nat Rev Drug Discov. 12:347–357.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Alvarez-Erviti L, Seow Y, Yin H, Betts C,
Lakhal S and Wood MJ: Delivery of siRNA to the mouse brain by
systemic injection of targeted exosomes. Nat Biotechnol.
29:341–345. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Lindenbergh MFS, Wubbolts R, Borg EGF, van
't Veld EM, Boes M and Stoorvogel W: Dendritic cells release
exosomes together with phagocytosed pathogen; potential
implications for the role of exosomes in antigen presentation. J
Extracell Vesicles. 9(1798606)2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ramos-Zayas Y, Franco-Molina MA,
Hernádez-Granados AJ, Zárate-Triviño DG, Coronado-Cerda EE,
Mendoza-Gamboa E, Zapata-Benavides P, Ramírez-Romero R,
Santana-Krymskaya SE, Tamez-Guerra R and Rodríguez-Padilla C:
Immunotherapy for the treatment of canine transmissible venereal
tumor based in dendritic cells pulsed with tumoral exosomes.
Immunopharmacol Immunotoxicol. 41:48–54. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Viaud S, Ploix S, Lapierre V, Théry C,
Commere PH, Tramalloni D, Gorrichon K, Virault-Rocroy P, Tursz T,
Lantz O, et al: Updated technology to produce highly immunogenic
dendritic cell-derived exosomes of clinical grade: A critical role
of interferon-γ. J Immunother. 34:65–75. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Segura E, Amigorena S and Théry C: Mature
dendritic cells secrete exosomes with strong ability to induce
antigen-specific effector immune responses. Blood Cells Mol Dis.
35:89–93. 2005.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Segura E, Nicco C, Lombard B, Véron P,
Raposo G, Batteux F, Amigorena S and Théry C: ICAM-1 on exosomes
from mature dendritic cells is critical for efficient naive T-cell
priming. Blood. 106:216–223. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Utsugi-Kobukai S, Fujimaki H, Hotta C,
Nakazawa M and Minami M: MHC class I-mediated exogenous antigen
presentation by exosomes secreted from immature and mature bone
marrow derived dendritic cells. Immunol Lett. 89:125–131.
2003.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Boni C, Bertoletti A, Penna A, Cavalli A,
Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R,
Fiaccadori F and Ferrari C: Lamivudine treatment can restore T cell
responsiveness in chronic hepatitis B. J Clin Invest. 102:968–975.
1998.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yu X, Wang Z, Chen H, Niu X, Dou Y, Yang
J, Tang Y and Diao Y: Serological and pathogenic analyses of fowl
adenovirus serotype 4 (FAdV-4) strain in muscovy ducks. Front
Microbiol. 9(1163)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yao T, Lv M, Ma S, Chen J, Zhang Y, Yu Y,
Zang G and Chen X: Ubiquitinated hepatitis d antigen-loaded
microvesicles induce a potent specific cellular immune response to
inhibit HDV replication in vivo. Microbiol Spectr.
9(e0102421)2021.PubMed/NCBI View Article : Google Scholar
|
